PMC:7228307 / 45543-45666
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 808 | 59-66 | Gene | denotes | FcγRIII | Gene:2214 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T373 | 80-102 | Body_part | denotes | Central nervous system | http://purl.org/sig/ont/fma/fma55675 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T29 | 80-102 | Body_part | denotes | Central nervous system | http://purl.obolibrary.org/obo/UBERON_0001017 |
| T30 | 88-102 | Body_part | denotes | nervous system | http://purl.obolibrary.org/obo/UBERON_0001016 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T798 | 59-61 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T799 | 80-102 | http://purl.obolibrary.org/obo/UBERON_0001017 | denotes | Central nervous system |
| T800 | 80-102 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | Central nervous system |
| T801 | 80-102 | http://www.ebi.ac.uk/efo/EFO_0000908 | denotes | Central nervous system |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 808 | 59-66 | Gene | denotes | FcγRIII | Gene:2214 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T264 | 0-123 | Sentence | denotes | Ublituximab CD20 IgG1 Afucosylated Selectively enhance FcγRIII interaction Central nervous system; oncology Phase III |
LitCovid-sample-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T27 | 80-102 | Body_part | denotes | Central nervous system | http://purl.obolibrary.org/obo/UBERON_0001017 |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T575 | 13-17 | Protein | denotes | CD20 | https://www.uniprot.org/uniprot/Q3C2E2|https://www.uniprot.org/uniprot/Q13963|https://www.uniprot.org/uniprot/P19437|https://www.uniprot.org/uniprot/P11836|https://www.uniprot.org/uniprot/P08984|https://www.uniprot.org/uniprot/B4DT24|https://www.uniprot.org/uniprot/A6NMS4 |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T372 | 80-102 | Body_part | denotes | Central nervous system | http://purl.org/sig/ont/fma/fma55675 |
LitCovid-sample-PD-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T21 | 80-102 | http://purl.obolibrary.org/obo/MAT_0000457 | denotes | Central nervous system |
| T22 | 88-102 | http://purl.obolibrary.org/obo/MAT_0000026 | denotes | nervous system |
LitCovid-sample-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T30 | 104-112 | Phenotype | denotes | oncology | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T264 | 0-123 | Sentence | denotes | Ublituximab CD20 IgG1 Afucosylated Selectively enhance FcγRIII interaction Central nervous system; oncology Phase III |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T30 | 104-112 | Phenotype | denotes | oncology | http://purl.obolibrary.org/obo/HP_0002664 |